Nissay Asset Management Corp Merck & Co., Inc. Transaction History

Nissay Asset Management Corp

$15 Billion
Q2 2024

A detailed history of Nissay Asset Management Corp transactions in Merck & Co., Inc. stock. As of the latest transaction made, Nissay Asset Management Corp holds 311,128 shares of MRK stock, worth $34.2 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

311,128

Previous 303,853 2.39%

Holding current value

$34.2 Million

Previous $40.1 Million 3.93%

% of portfolio

0.26%

Previous 0.28%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$123.8 - $132.96 $900,645 - $967,284	7,275 Added 2.39%	311,128 $38.5 Million
Q1 2024 May 15, 2024	SELL	$113.24 - $131.95 $20,496 - $23,882	-181 Reduced 0.06%	303,853 $40.1 Million
Q4 2023 Feb 14, 2024	SELL	$100.18 - $109.02 $660,586 - $718,877	-6,594 Reduced 2.12%	304,034 $33.1 Million
Q3 2023 Nov 14, 2023	BUY	$102.95 - $114.33 $645,496 - $716,849	6,270 Added 2.06%	310,628 $32 Million
Q2 2023 Aug 14, 2023	SELL	$108.61 - $118.38 $458,660 - $499,918	-4,223 Reduced 1.37%	304,358 $35.1 Million
Q1 2023 May 15, 2023	SELL	$102.94 - $114.86 $1.11 Million - $1.24 Million	-10,783 Reduced 3.38%	308,581 $32.8 Million
Q4 2022 Feb 14, 2023	SELL	$87.44 - $112.11 $2.34 Million - $3.01 Million	-26,812 Reduced 7.75%	319,364 $35.4 Million
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $2.3 Million - $2.59 Million	27,242 Added 8.54%	346,176 $29.8 Million
Q2 2022 Aug 15, 2022	BUY	$83.49 - $94.64 $928,659 - $1.05 Million	11,123 Added 3.61%	318,934 $29.1 Million
Q1 2022 May 16, 2022	BUY	$73.51 - $82.4 $339,322 - $380,358	4,616 Added 1.52%	307,811 $25.3 Million
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $250,739 - $314,083	3,469 Added 1.16%	303,195 $23.2 Million
Q3 2021 Nov 10, 2021	SELL	$71.68 - $78.83 $160,778 - $176,815	-2,243 Reduced 0.74%	299,726 $22.5 Million
Q2 2021 Aug 13, 2021	BUY	$70.31 - $77.77 $718,779 - $795,042	10,223 Added 3.5%	301,969 $23.5 Million
Q1 2021 May 11, 2021	SELL	$68.86 - $81.11 $521,889 - $614,732	-7,579 Reduced 2.53%	291,746 $22.5 Million
Q4 2020 Feb 08, 2021	SELL	$71.77 - $79.65 $2.9 Million - $3.22 Million	-40,365 Reduced 11.88%	299,325 $24.5 Million
Q3 2020 Oct 20, 2020	SELL	$73.18 - $82.95 $2.85 Million - $3.23 Million	-38,947 Reduced 10.29%	339,690 $28.2 Million
Q2 2020 Jul 27, 2020	BUY	$70.42 - $80.13 $647,934 - $737,276	9,201 Added 2.49%	378,637 $29.3 Million
Q1 2020 May 05, 2020	BUY	$63.36 - $87.82 $429,960 - $595,946	6,786 Added 1.87%	369,436 $28.4 Million
Q4 2019 Feb 14, 2020	BUY	$77.58 - $87.54 $2 Million - $2.25 Million	25,720 Added 7.63%	362,650 $33 Million
Q3 2019 Nov 14, 2019	SELL	$76.08 - $82.93 $4.99 Million - $5.44 Million	-65,612 Reduced 16.3%	336,930 $28.4 Million
Q2 2019 Aug 07, 2019	SELL	$69.84 - $81.59 $936,973 - $1.09 Million	-13,416 Reduced 3.23%	402,542 $33.8 Million
Q1 2019 May 03, 2019	SELL	$69.58 - $79.36 $3 Million - $3.42 Million	-43,135 Reduced 9.4%	415,958 $34.6 Million
Q4 2018 Feb 06, 2019	BUY	$65.24 - $75.71 $2.79 Million - $3.23 Million	42,721 Added 10.26%	459,093 $35.1 Million
Q3 2018 Oct 30, 2018	BUY	$57.69 - $67.84 $5.45 Million - $6.41 Million	94,491 Added 29.36%	416,372 $29.5 Million
Q2 2018 Aug 08, 2018	SELL	$50.83 - $59.72 $1.01 Million - $1.19 Million	-19,878 Reduced 5.82%	321,881 $19.5 Million
Q1 2018 May 14, 2018	SELL	$50.96 - $59.23 $1.08 Million - $1.26 Million	-21,246 Reduced 5.85%	341,759 $18.6 Million
Q4 2017 Feb 14, 2018	BUY	$51.62 - $61.64 $18.7 Million - $22.4 Million	363,005	363,005 $20.4 Million

Others Institutions Holding MRK

# of Institutions

3,828

Shares Held

1.91B

Call Options Held

13.4M

Put Options Held

10.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $278B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nissay Asset Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Nissay Asset Management Corp with notifications on news.

Account

Nissay Asset Management Corp Merck & Co., Inc. Transaction History